Mechanisms Underlying Inflammation in Neurodegeneration
By Christopher K. Glass, Kaoru Saijo, Beate Winner, M. Marchetto, Fred H. Gage. Cell, 2010
3,377 citations recorded by the source corpus.
Inflammation is associated with many neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis. In this Review, we discuss inducers, sensors, transducers, and effectors of neuroinflammation that contribute to neuronal dysfunction and death. Although inducers of inflammation may be generated in a disease-specific manner, there is evidence for a remarkable convergence in the mechanisms responsible for the sensing, transduction, and amplification of inflammatory processes that result in the production of neurotoxic mediators. A major unanswered question is whether pharmacological inhibition of inflammation pathways will be able to safely reverse or slow the course of disease.
Subfields: Biological Psychiatry, Neurology, Physiology
View Paper: https://www.semanticscholar.org/paper/e44ffa3a0a1d5befa3dcd1b022d80d1c32978fc6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biological Psychiatry
In Neurology
- Berislav Zlokovic
- R. Ransohoff
- Christopher K. Glass
- Kaoru Saijo
- L. Volpicelli-Daley
- D. Bailey
- E. K. Kim
- Yuanyuan Tang
In Physiology
Citations in the corpus
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. (2014, background): “MS is an inflammatory autoimmune disease in which myelin sheaths around the axons of the brain and spinal cord are damaged, leading to inflammation, demyelination and axon degeneration in the central nervous system (CNS) (Glass et al., 2010).”
- Neurodegenerative disease and adult neurogenesis (2011, background): “Recently, glial and immune cells have been shown to have increasing importance in these diseases (Glass et al., 2010).”
- Excitotoxicity: bridge to various triggers in neurodegenerative disorders. (2013, background): “Pharmacological experiments using NO donors, NOS inhibitors, or exogenous substrates (such as reduced hemoglobin) for competitive reactions with NO, have suggested that NO is linked to neuronal cell death (Glass et al., 2010; Kumar et al., 2010).”
- Neuronal Cell Death. (2018, neutral): “Proinflammatory cytokines such as IL-1 and TNF- can induce neuronal cell death in culture and in vivo (253, 459), but in general, this is indirect toxicity mediated by activation of glia (498, 669).”
- Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases (2015, background): “Microglial activation is the principal component of neuroinflammation in the central nervous system (CNS), which provides the first line of defense whenever injury or disease occurs [2, 4].”
- Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain (2013, background): “The dysregulation of cytokines and chemokines is a central feature in the development of neuroinflammation, neurodegeneration and demyelination in the CNS [43, 44], neuritis and axonal degeneration in the PNS [9], and conditions of neuropathic pain [10, 49].”
- Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease. (2018, background): “Many PD therapeutic trials have targeted microglia to limit inflammation and block the self-perpetuating ROS production cycle, however there has yet to be success in clinical trials using anti-inflammatories to slow PD progression (Glass et al., 2010).”
- The Central Nervous System and the Gut Microbiome (2016, background): “Neuroinflammation is postulated to play a key role in the pathology of neurodegenerative diseases (Cappellano et al., 2013; Glass et al., 2010).”
- Neuroinflammation in Parkinson’s disease and its potential as therapeutic target (2015, background): “utes to the enhanced death of DA neurons in the SNpc during neurodegeneration [11, 54].”
- Role of neuroinflammation in neurodegenerative diseases (Review) (2016, neutral): “Accordingly, specific inducers of inflammation associated with neurodegenerative diseases converge in mechanisms responsible in the sensing, transduction and amplification of the inflammatory processes that result in the production of neurotoxic mediators, such as cytokines and interleukins (18,19).”
- An environment-dependent transcriptional network specifies human microglia identity (2017, background): “1 as an essential lineagedetermining transcription factor (LDTF) (21, 22), highly efficient phagocytic and tissue debris clearance abilities (2, 5), and the ability to quickly trigger an inflammatory response following detection of pathogens or tissue damage (23).”